This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Permissions Request Permissions Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (39) Citing Articles via Google Scholar Google Scholar Articles by Borrill, Z. Articles by Singh, D. Search for Related Content PubMed PubMed Citation Articles by Borrill, Z. Articles by Singh, D.

Reproducibility of exhaled breath condensate pH in chronic obstructive pulmonary disease

Medicines Evaluation Unit, North West Lung Centre, Wythenshawe Hospital, Manchester, UK

CORRESPONDENCE: Z. Borrill, Wythenshawe Hospital, North West Lung Centre, Manchester M23 9LT, UK. Fax: 44 1612912243. E-mail: zborrill@meu.org.uk

Keywords: Chronic obstructive pulmonary disease, exhaled breath condensates

Received: July 21, 2004
Accepted October 20, 2004

Increasingly, exhaled breath condensate (EBC) is being used to sample airway fluid from the lower respiratory tract. EBC pH may be a biomarker of airway inflammation in chronic obstructive pulmonary disease (COPD). In this study, the reproducibility of EBC pH in COPD was investigated.

A total of 36 COPD patients and 12 healthy nonsmoking subjects participated in several investigations: duration of argon deaeration, within-sample variability, effect of freezing, leaving samples at room temperature, nose-peg use, within- (WD) and between-day (BD) variability. Analysis of repeated measurements was performed using the Bland–Altman method with limits of agreement (LOA; mean difference±2SD). Wider LOA indicate greater variability.

EBC pH became significantly higher with argon deaeration for 5 min. Variability during sample analysis was minimal; LOA of within-sample variability, freezing for 3 months and leaving at room temperature for 3 h were –0.29–0.45, –0.37–0.42 and –0.13–0.09, respectively. In contrast, variability due to nose-peg use (LOA –1.46–1.99), WD (LOA –1.50–2.48) and BD variability (LOA –2.52–3.02) were higher in COPD. In healthy nonsmoking subjects, nose-peg use (LOA –0.27–0.23), WD (LOA –0.33–0.40) and BD variability (LOA –0.46–0.44) were more reproducible.

In conclusion, the variability of exhaled breath condensate pH in chronic obstructive pulmonary disease patients is mainly due to changes in airway pH over time, which are not seen in healthy nonsmoking subjects. Reasons for these fluctuations in exhaled breath condensate pH are unclear and require further investigation.

This article has been cited by other articles:

				R. Do, K. H. Bartlett, H. Dimich-Ward, W. Chu, and S. M. Kennedy Biomarkers of Airway Acidity and Oxidative Stress in Exhaled Breath Condensate from Grain Workers Am. J. Respir. Crit. Care Med., November 15, 2008; 178(10): 1048 - 1054. [Abstract] [Full Text] [PDF]

				Z. L. Borrill, K. Roy, and D. Singh Exhaled breath condensate biomarkers in COPD Eur. Respir. J., August 1, 2008; 32(2): 472 - 486. [Abstract] [Full Text] [PDF]

				E Sapey, D Bayley, A Ahmad, P Newbold, N Snell, and R A Stockley Inter-relationships between inflammatory markers in patients with stable COPD with bronchitis: intra-patient and inter-patient variability Thorax, June 1, 2008; 63(6): 493 - 499. [Abstract] [Full Text] [PDF]

				M. Cazzola, W. MacNee, F. J. Martinez, K. F. Rabe, L. G. Franciosi, P. J. Barnes, V. Brusasco, P. S. Burge, P. M. A. Calverley, B. R. Celli, et al. Outcomes for COPD pharmacological trials: from lung function to biomarkers Eur. Respir. J., February 1, 2008; 31(2): 416 - 469. [Abstract] [Full Text] [PDF]

				B. Balbi, P. Pignatti, M. Corradi, P. Baiardi, L. Bianchi, G. Brunetti, A. Radaeli, G. Moscato, A. Mutti, A. Spanevello, et al. Bronchoalveolar lavage, sputum and exhaled clinically relevant inflammatory markers: values in healthy adults Eur. Respir. J., October 1, 2007; 30(4): 769 - 781. [Abstract] [Full Text] [PDF]

				Z. L. Borrill, J. A. Smith, J. Naylor, A. A. Woodcock, and D. Singh The effect of gas standardisation on exhaled breath condensate pH. Eur. Respir. J., July 1, 2006; 28(1): 251 - 252. [Full Text] [PDF]

				P. J. Barnes, B. Chowdhury, S. A. Kharitonov, H. Magnussen, C. P. Page, D. Postma, and M. Saetta Pulmonary Biomarkers in Chronic Obstructive Pulmonary Disease Am. J. Respir. Crit. Care Med., July 1, 2006; 174(1): 6 - 14. [Abstract] [Full Text] [PDF]

				R. M. Effros, R. Casaburi, J. Su, M. Dunning, J. Torday, J. Biller, and R. Shaker The Effects of Volatile Salivary Acids and Bases on Exhaled Breath Condensate pH Am. J. Respir. Crit. Care Med., February 15, 2006; 173(4): 386 - 392. [Abstract] [Full Text] [PDF]

				A. O. Paget-Brown, L. Ngamtrakulpanit, A. Smith, D. Bunyan, S. Hom, A. Nguyen, and J. F. Hunt Normative Data for pH of Exhaled Breath Condensate. Chest, February 1, 2006; 129(2): 426 - 430. [Abstract] [Full Text] [PDF]

				I. Horvath, J. Hunt, P. J. Barnes, and On behalf of the ATS/ERS Task Force on Exhaled Bre Exhaled breath condensate: methodological recommendations and unresolved questions Eur. Respir. J., September 1, 2005; 26(3): 523 - 548. [Abstract] [Full Text] [PDF]